This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norton, P. A.
Right arrow Articles by Block, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norton, P. A.
Right arrow Articles by Block, T. M.

 Previous Article  |  Next Article 

Journal of Virology, May 2003, p. 5503-5506, Vol. 77, No. 9
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.9.5503-5506.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Hepatitis B Virus-Mediated Changes of Apolipoprotein mRNA Abundance in Cultured Hepatoma Cells

Pamela A. Norton,* Qiaoke Gong, Anand S. Mehta, Xuanyong Lu, and Timothy M. Block

Jefferson Center for Biomedical Research and Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Doylestown, Pennsylvania

Received 4 September 2002/ Accepted 3 February 2003

An inverse correlation between hepatitis B virus (HBV) and steady-state levels of apolipoprotein AI and CIII mRNAs was observed in two hepatoma cell lines. Analysis of a third line containing an inducible viral genome implicated viral pregenomic RNA in apolipoprotein mRNA reduction. We conclude that HBV alters infected cells despite the absence of overt cytopathogenicity.


* Corresponding author. Mailing address: Jefferson Center for Biomedical Research, 700 E. Butler Ave., Doylestown, PA 18901. Phone: (215) 489-4903. Fax: (215) 489-4920. E-mail: pamela.norton{at}mail.tju.edu.


Journal of Virology, May 2003, p. 5503-5506, Vol. 77, No. 9
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.9.5503-5506.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Choudhari, S. R., Khan, M. A., Harris, G., Picker, D., Jacob, G. S., Block, T., Shailubhai, K. (2007). Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod. Molecular Cancer Therapeutics 6: 112-121 [Abstract] [Full Text]